Faculty Opinions recommendation of IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.

Alberto Mantovani

doi:10.3410/f.733514952.793551352

Related publications

Dataset

Faculty Opinions recommendation of The role of myeloid cells in cancer therapies.

Alberto Mantovani

Dataset

Faculty Opinions recommendation of A lineage of myeloid cells independent of Myb and hematopoietic stem cells.

Alberto Mantovani

Article2020

Olaparib for Metastatic Castration-Resistant Prostate Cancer

Johann S. de Bono, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Niven Mehra, Carsten Goessl, Jinyu Kang, Joseph E. Burgents, Wenting Wu, Alexander Kohlmann, Carrie A. Adelman, Maha Hussain

Article2019

New combination therapies for castration-resistant prostate cancer

Mitchell G. Lawrence, Laura H. Porter, Daisuke Obinata, Shahneen Sandhu, Luke A. Selth, Stephen Q. Wong, Nicholas Choo, David Pook, Carmel Pezaro, David L. Goode, Ashlee K. Clark, Melissa Papargiris, Roxanne Toivanen, Scott M. Dehm, Scott M CASCADE, Scott M kConfab, Heather Thorne, Wayne D. Tilley, Richard B. Pearson, Ross D. Hannan, Declan G. Murphy, Mark Frydenberg, Luc Furic, Renea A. Taylor,

Article2023

Heterogeneity of canonical prostate cancer markers across lesions in metastatic castration-resistant prostate cancer.

Anna Trigos, Anupama Pasam, Andrisha–Jade Inderjeeth, Lachlan D. Cain, Sirui Weng, Vinita Gupta, Beate Sable, Katherine Paweletz, Julie M. Bailis, Yangyi Zhang, Yuzhou Feng, A. Antón, Ben Tran, Catherine Mitchell, Shahneen Sandhu